The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness analysis of VEGF-C: A novel predictive biomarker for response to bevacizumab in the neoadjuvant therapy of early breast cancer patients.
 
Patricia Renee Blank
No Relationships to Disclose
 
Sibylle Loibl
No Relationships to Disclose
 
Barbro Kristina Linderholm
No Relationships to Disclose
 
Stefano Caramuta
No Relationships to Disclose
 
Valentina Nekljudova
No Relationships to Disclose
 
Thomas D. Szucs
No Relationships to Disclose
 
Joris van Stiphout
No Relationships to Disclose
 
Zanfina Ademi
No Relationships to Disclose
 
Gunter Von Minckwitz
Employment - GBG Forschungs
Leadership - GBG Forschungs
Stock and Other Ownership Interests - GBG Forschungs
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Matthias Schwenkglenks
No Relationships to Disclose